(Q40738751)

23 September 2017

title

Cytotoxic T lymphocyte mediated recognition of human pancreatic cancer cells (English)

1 reference

23 September 2017

author

Wolfram Trudo Knoefel

Claus Ferdinand Eisenberger

5

object named as

Wolfram Trudo Knoefel

0 references

4

object named as

Claus Ferdinand Eisenberger

0 references

author name string

Matthias Peiper

1

1 reference

23 September 2017

Takeo Sato

2

1 reference

23 September 2017

Thomas Streichert

3

1 reference

23 September 2017

Jakob Robert Izbicki

6

1 reference

23 September 2017

language of work or name

English

0 references

publication date

1 May 2002

1 reference

International Journal of Cancer

23 September 2017

published in

1 reference

23 September 2017

volume

99

1 reference

23 September 2017

issue

1

1 reference

23 September 2017

page(s)

88-92

1 reference

Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators

23 September 2017

cites work

1 reference

Innovative treatments for pancreatic cancer.

21 January 2018

1 reference

Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes

21 January 2018

1 reference

Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide

21 January 2018

1 reference

Recognition of breast cancer-associated peptides by tumor-reactive, HLA-class I restricted allogeneic cytotoxic T lymphocytes

21 January 2018

1 reference

Human tumor antigens recognized by T lymphocytes

21 January 2018

1 reference

Progress in human tumour immunology and immunotherapy

21 January 2018

1 reference

MHC ligands and peptide motifs: first listing

21 January 2018

1 reference

Induction of Tumor-Specific Cytotoxic T Lymphocytes from Regional Lymph Node Lymphocytes of Human Breast Cancer

21 January 2018

1 reference

Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601.

21 January 2018

1 reference

Lysis of human pancreatic adenocarcinoma cells by autologous HLA-class I-restricted cytolytic T-lymphocyte (CTL) clones

21 January 2018

1 reference

Human pancreatic cancer cells (MPanc-96) recognized by autologous tumor-infiltrating lymphocytes after in vitro as well as in vivo tumor expansion

21 January 2018

1 reference

From defined human tumor antigens to effective immunization?

21 January 2018

1 reference

Purification of antigenic peptide from murine hepatoma cells recognized by Class-I major histocompatibility complex molecule-restricted cytotoxic T-lymphocytes induced with B7-1-gene-transfected hepatoma cells

21 January 2018

1 reference

Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes

21 January 2018

1 reference

TGF-beta 1 pretreatment impairs the allostimulatory function of human bone marrow-derived antigen-presenting cells for both naive and primed T cells

21 January 2018

1 reference

Generation of peptide-specific cytotoxic T lymphocytes using allogeneic dendritic cells capable of lysing human pancreatic cancer cells

21 January 2018

1 reference

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

21 January 2018

1 reference

Study of HLA class I restriction and the directed antigens of cytotoxic T lymphocytes at the tumor sites of ovarian cancer

21 January 2018

1 reference

Autologous tumour-specific cytotoxic T-cell clone established from tumour-infiltrating lymphocytes (TIL) of malignant ascites in the absence of recombinant interleukin 2(rIL2): activation by autologous tumour cell alone

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/IJC.10280

1 reference

23 September 2017

1 reference